Loxapine

洛沙平

Report date: 2026/04/16 20:00:17

Base Information

Drug NameLoxapine
Drug Alias NameAdasuveSUM-3170CL-62362
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsBipolar I DisorderSchizophreniaBipolar Disorder +[8] 
Global Approved IndicationsSchizophreniaBipolar DisorderBipolar and Related Disorders +[4] 
Approved Indications in ChinaSchizophreniaBipolar and Related Disorders
Original Approved Country/TerritoryUnited States
Original Approved Date2012/12/21
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlexza Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNova Pneuma IncFerrer Internacional SaZhaoke Pharmaceutical (Hefei) Co Ltd
Inactive CompaniesLee'S Pharmaceutical LtdAlexza Pharmaceuticals Inc
Active IndicationsSchizophreniaBipolar DisorderBipolar and Related Disorders +[4] 
Inactive IndicationsBipolar I DisorderSmokingMigraine Disorders +[4] 

Other Information

ATC CodeN05AH01
Related LinksWikipediaDrugBankKEGG